- Home
- XIN vs PYPD Comparison
XIN vs PYPD Comparison
Compare XIN & PYPD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XIN
- PYPD
- Stock Information
- Founded
- XIN 1997
- PYPD 2008
- Country
- XIN China
- PYPD Israel
- Employees
- XIN N/A
- PYPD N/A
- Industry
- XIN Homebuilding
- PYPD Medical/Dental Instruments
- Sector
- XIN Consumer Discretionary
- PYPD Health Care
- Exchange
- XIN Nasdaq
- PYPD Nasdaq
- Market Cap
- XIN 15.9M
- PYPD 16.5M
- IPO Year
- XIN N/A
- PYPD 2020
- Fundamental
- Price
- XIN $2.27
- PYPD $3.22
- Analyst Decision
- XIN
- PYPD Strong Buy
- Analyst Count
- XIN 0
- PYPD 2
- Target Price
- XIN N/A
- PYPD $12.00
- AVG Volume (30 Days)
- XIN 27.5K
- PYPD 29.0K
- Earning Date
- XIN 01-01-0001
- PYPD 02-12-2025
- Dividend Yield
- XIN N/A
- PYPD N/A
- EPS Growth
- XIN N/A
- PYPD N/A
- EPS
- XIN N/A
- PYPD N/A
- Revenue
- XIN $667,143,185.00
- PYPD N/A
- Revenue This Year
- XIN N/A
- PYPD N/A
- Revenue Next Year
- XIN N/A
- PYPD N/A
- P/E Ratio
- XIN $0.28
- PYPD N/A
- Revenue Growth
- XIN N/A
- PYPD N/A
- 52 Week Low
- XIN $1.92
- PYPD $2.37
- 52 Week High
- XIN $7.05
- PYPD $9.20
- Technical
- Relative Strength Index (RSI)
- XIN 27.87
- PYPD 53.21
- Support Level
- XIN $2.44
- PYPD $2.37
- Resistance Level
- XIN $2.65
- PYPD $3.13
- Average True Range (ATR)
- XIN 0.25
- PYPD 0.32
- MACD
- XIN -0.04
- PYPD 0.05
- Stochastic Oscillator
- XIN 1.83
- PYPD 64.89
About XIN Xinyuan Real Estate Co Ltd
Xinyuan Real Estate Co Ltd operates as a real estate developer and property manager in China. It focuses on developing residential projects, which typically consist of multiple residential buildings that include multi-layer apartment buildings, and others. Its several projects include auxiliary services and amenities such as retail outlets, leisure and health facilities, kindergartens, and schools. It aims to provide comfortable and convenient real estate-related products and services to middle-class consumers.
About PYPD PolyPid Ltd.
PolyPid Ltd is a clinical-stage biopharmaceutical company engaged in the research and development of products based on PLEX (Polymer-Lipid Encapsulation MatriX), the company's proprietary drug delivery technology. PLEX is capable of encapsulating many types of drugs to enable targeted, localized drug delivery into the body over extended periods of time with pre-determined release rates thus optimizing drug treatment regimens. BonyPid, PolyPid, Opzifend, Ssisurg, Elyfssi, Baczenssi, Opzifend and Bacyssio are trademarks of the company. Its product candidate include D-PLEX100 for prevention of SSI in soft tissue and OncoPLEX which can be a potential Intra-tumoral therapy.